Editorial: HER2 testing in patients with breast cancer
Source: BMJ
This editorial discusses HER2 testing in relation to the use of HER2 targeted drugs for breast cancer. The author comments,” However, to allow proper use of HER2 targeted drugs, results from HER2 testing need to be available in a timely manner. A recent survey of surgeons in the United Kingdom found, worryingly, that only half of patients with invasive cancer had a HER2 result available when treatment was initially discussed”.
Library & Knowledge Service blog 